In this week’s issue of The Savvy Diabetic: Tandem secures FDA approval for Control-IQ+ use in pregnancy Senseonics Announces Commencement of $80 Million Public Offering True Metrix Glucometers Linked With 114 Injuries Medical Board Wants AI Doctor Program ‘Immediately Suspended’ Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy Medicare Advantage health plans may cut extra benefits in 2027 Tandem secures FDA approval for Control-IQ+ use in pregnancy by Salong Debbarma for MedicalDevice-Network.com, 28 April 2026.
No comments yet. Log in to reply on the Fediverse. Comments will appear here.